Correlation between renin-angiotensin system (RAS) related genes, type 2 diabetes, and cancer: Insights from

Luciana Xavier Pereira1, Laryssa Cristina Alves da Silva1, Alexya de Oliveira Feitosa1

  • 1Federal University of Alagoas, Campus Arapiraca. Av. Manoel Severino Barbosa, Bom Sucesso, Arapiraca, AL, 57309-005, Brazil.

Insights

This study identifies novel biomarkers in type 2 diabetes and cancer by integrating multi-omics data. These findings offer new targets for early detection and therapy in associated cancers.

Area of Science:

  • Biomolecular mechanisms
  • Systems biology
  • Multi-omics integration

Background:

  • Type 2 diabetes mellitus (DM) is linked to increased cancer risk, but underlying molecular mechanisms are unclear.
  • The renin-angiotensin system (RAS) is implicated in DM-associated cancer risk.
  • An integrative multi-omics approach is needed to elucidate these complex relationships.

Purpose of the Study:

  • To identify novel reporter biomolecules and pathways linking type 2 diabetes and associated cancers.
  • To explore the role of RAS in cancer initiation and progression within the context of type 2 diabetes.
  • To discover potential systems biomarkers for screening and therapeutic targets.

Main Methods:

  • Meta-analysis of transcriptome data from type 2 diabetes and various cancers.
  • Integration of gene expression profiles with genome-scale biomolecular networks.
  • Pathway analysis and immunohistochemistry to identify and validate biomarkers at RNA, protein, and metabolite levels.

Main Results:

  • Novel biomarker candidates, including metabolites (aminoacyl-tRNA biosynthesis, ABC transporters), were identified.
  • Differentially expressed genes (DEGs) were detected in various tissues between normal and diabetic patients.
  • RAS-related genes and enriched cancer pathways were identified in pancreatic islets, blood, and skeletal muscle.
  • Discrepancies between mRNA and protein expression (e.g., EDNRB) highlight post-translational modifications.

Conclusions:

  • Metabolites involved in aminoacyl-tRNA biosynthesis and ABC transporters show potential as novel biomarkers and therapeutic targets.
  • The identified biomolecules and pathways offer significant potential for screening and therapeutic strategies in type 2 diabetes and cancer.
  • Further experimental and clinical analysis is warranted to validate these findings.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
986
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H01:13

meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H

All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.6K
Correlation of Experimental Data01:23

Correlation of Experimental Data

Dimensional analysis simplifies complex physical problems and guides experimental investigations, but it does not provide complete solutions. It identifies the dimensionless groups that influence a phenomenon, but experimental data is needed to establish the specific relationships and validate theoretical predictions.
For example, a spherical particle moving through a viscous fluid experiences drag. Dimensional analysis shows that the drag force depends on the particle's diameter, velocity,...
481
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
470